Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. See what's happening in the market right now with MarketBeat's real-time news feed. The company reported ($1.00) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.45. CMPS 45.33 2.83 (6.66%). Shares of Compass Pathways (NASDAQ: CMPS) have soared since the company's recent stock market debut as support grows for the use of popular recreational drugs to combat depression. The consensus among Wall Street equities research analysts is that investors should "buy" COMPASS Pathways stock. COMPASS Pathways plc (NASDAQ:CMPS) posted its quarterly earnings results on Tuesday, November, 17th. COMPASS Pathways has received a consensus rating of Buy. ), COMPASS Pathways has received 2 “underperform” votes. © American Consumer News, LLC dba MarketBeat® 2010-2021. Do Not Sell My Information. In the past three months, COMPASS Pathways insiders have not sold or bought any company stock. Receive a free world-class investing education from MarketBeat. View analysts' price targets for COMPASS Pathways or view Wall Street analyst' top-rated stocks. Get daily stock ideas top-performing Wall Street analysts. All rights reserved. According to present data Compass Pathways Plc - ADR's CMPS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 0 shares are currently held short). Post-Market 0.33 (0.73%) Learn more. Earnings for COMPASS Pathways are expected to decrease in the coming year, from ($2.39) to ($4.37) per share. COMPASS Pathways' lock-up period expires on Wednesday, March 17th. Découvrez comment nous utilisons vos informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Shares of Compass Pathways PLC CMPS, +42.91% pointed north out of the gate, as the first trade was 37.6% above the initial public offering price. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. COMPASS Pathways does not currently pay a dividend. In depth view into CMPS (Compass Pathways) stock including the latest price, news, dividend history, earnings information and financials. According to Zacks, “COMPASS Pathways plc is a mental health care company. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. View all of CMPS's competitors. CMPS: Get the latest COMPASS Pathways stock price and detailed information including CMPS news, historical charts and realtime prices. Learn about financial terms, types of investments, trading strategies and more. The official website for COMPASS Pathways is www.compasspathways.com. COMPASS Pathways has received 81.82% “outperform” votes from our community. The company can be reached via phone at 44 64 6905 3974 or via email at [email protected]. Company profile page for Compass Pathways Plc including stock price, company news, press releases, executives, board members, and contact information This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. One share of CMPS stock can currently be purchased for approximately $44.93. 5 equities research analysts have issued 12 month price targets for COMPASS Pathways' stock. COMPASS Pathways. At that level they are trading at 52.94% discount to the analyst consensus target price of 0.00. The demand for shares of the company still looks higher than the supply. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Shares fell 2.8% to 34.81 on the stock market today, off session lows of 33.13.Compass Pathways stock is in an IPO base with a 47.39 buy point.The stock has a … Source: Compass Pathways Investor Deck Financials Overview. Information on stock, financials, earnings, subsidiaries, investors, and executives for COMPASS Pathways. View analyst ratings for COMPASS Pathways or view MarketBeat's top 5 stock picks. Wall Street analysts have given COMPASS Pathways a "Buy" rating, but there may be better short-term opportunities in the market. COMPASS Pathways plc (NASDAQ:CMPS) traded at $42.5 at close of the session on Friday, Jan 15, made a downturn move of -0.77% on its previous day’s price. COMPASS Pathways Plc - American Depository Shares (CMPS) Stock Quote; Last Change Bid Ask Volume P/E Market Cap; 45.61 +0.28: 45.36: 45.74: 107K-0.0 Share your opinion and gain insight from other stock traders and investors. Compass Pathways Stock. Get the hottest stocks to trade every day before the market opens 100% free. Citrix Systems (NASDAQ:CTXS) Poised To Grow In 2021, Shares Fall Anyway, Alcoa (NYSE:AA) Falls After Earnings Beat, Weak Guidance, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Start Your Risk-Free Trial Subscription Here, Trump returns to a business empire ravaged by pandemic, Germany's Merkel stands by Russia pipeline that US opposes, Biden's climate steps could have big impact on energy firms, Biden Cabinet: Buttigieg urges big funds for Transportation, FDA approves 1st long-acting HIV drug combo, monthly shots, 3D Printing Stocks Offering Another Dimension of Gains, Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive, Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels, Proctor & Gamble (NYSE:PG) Pulls Back After Shaky Guidance, It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet. COMPASS Pathways has a market capitalization of $1.56 billion. You may vote once every thirty days. ET Only 15.78% of the stock of COMPASS Pathways is held by institutions. The total size of the offering was $127,500,000 based on an initial share price of $17.00. Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression. You can opt out at any time. Sign-up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Yahoo fait partie de Verizon Media. 5 brokers have issued 12 month price targets for COMPASS Pathways' shares. Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Contact Us Please note that we are not able to diagnose, advise, provide acute or chronic care, or make treatment referrals. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. Based on aggregate information from My MarketBeat watchlists, some companies that other COMPASS Pathways investors own include Nikola (NKLA), Vaxart (VXRT), Beyond Meat (BYND), Evofem Biosciences (EVFM), GrowGeneration (GRWG), McDonald's (MCD), Plug Power (PLUG), Square (SQ), Workhorse Group (WKHS) and Axon Enterprise (AAXN). COMPASS Pathways (NASDAQ:CMPS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. Find related and similar companies as … It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Are Big Things Ahead for SolarEdge Technologies (NASDAQ:SEDG)? Learn more. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. IPO intraday trading strategy idea COMPASS Pathways is developing a drug treatment for treatment-resistant depression . COMPASS Pathways has received no research coverage in the past 90 days. Founded in 2016, Compass Pathways is located on the outskirts of Karl Pilkington’s stomping grounds – Manchester, England – where the company managed to raise just over $116 million in funding from around a dozen …